← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 8, 2022First marketed drug
May 20, 2020First NDA
May 20, 2020Last known activity
Feb 8, 2022
Acquired by General Electric → Danaher on May 6, 2021
Timeline
2010s
- Jan 1, 2018
Zionexa— Founded
- Feb 25, 2019
Danaher— Now
2020s
- May 20, 2020
fluoroestradiol— Marketing Organization
- May 20, 2020
fluoroestradiol— NDA Organization
- May 20, 2020
fluoroestradiol— NDA Secondary Org
- May 6, 2021
General Electric— Acquired By
Drugs by trial phase (1 distinct, 1 trials)
Phase 4 (1 own, 0 via acquisition)
Marketed drugs (1)
Recent trials (1)
- NCT05486182Lead sponsorPhase 4Feb 8, 2022
Details
- Founded
- New York, NY, US Jan 1, 2018
- First NDA
- May 20, 2020
- Last known activity
- Feb 8, 2022